🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 2 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/01/2022 72,44 73,05 71,97 72,18 -0,04% 1,49% 7.799.500
04/01/2022 72,61 73,40 72,18 72,21 -0,51% 1,68% 6.784.100
03/01/2022 72,27 72,69 71,61 72,58 -0,04% 1,49% 6.622.500
31/12/2021 73,25 73,48 72,45 72,61 -1,02% 1,41% 5.736.800
30/12/2021 73,66 74,12 73,26 73,36 -0,38% 1,17% 3.238.700
29/12/2021 73,00 73,73 72,61 73,64 +0,92% 1,53% 5.893.900
28/12/2021 72,87 73,39 72,79 72,97 +0,14% 0,82% 3.802.600
27/12/2021 72,28 72,88 71,92 72,87 +0,54% 1,33% 4.298.800
23/12/2021 72,57 72,82 72,18 72,48 +0,07% 0,88% 5.096.300
22/12/2021 71,59 72,46 70,66 72,43 +0,82% 2,51% 6.015.400
21/12/2021 72,47 72,59 71,63 71,84 -0,87% 1,32% 8.786.700
20/12/2021 72,00 72,52 71,45 72,47 +0,36% 1,49% 7.616.900
17/12/2021 72,22 72,69 71,65 72,21 -0,14% 1,44% 12.226.000
16/12/2021 71,35 72,83 71,06 72,31 +1,54% 2,48% 10.530.000
15/12/2021 70,55 71,42 69,94 71,21 +0,98% 2,10% 8.040.300
14/12/2021 69,87 70,80 69,76 70,52 -0,13% 1,49% 7.244.900
13/12/2021 70,12 70,88 69,60 70,61 +0,51% 1,83% 6.883.600
10/12/2021 70,18 70,94 69,60 70,25 -0,07% 1,91% 5.352.500
09/12/2021 69,89 70,73 69,24 70,30 +0,85% 2,13% 5.829.300
08/12/2021 69,91 70,48 68,91 69,71 +0,09% 2,25% 6.386.900
07/12/2021 69,60 69,90 68,91 69,65 +0,22% 1,42% 6.438.000
06/12/2021 69,46 70,80 69,42 69,50 -0,09% 1,99% 7.049.400
03/12/2021 70,00 70,46 69,31 69,56 -0,16% 1,64% 8.328.200
02/12/2021 69,17 70,29 68,83 69,67 +1,07% 2,11% 9.411.700
01/12/2021 69,03 70,02 68,65 68,93 +0,00% 1,98% 8.518.300
30/11/2021 70,47 70,90 68,64 68,93 -2,43% 3,21% 15.465.500
29/11/2021 70,40 71,32 70,21 70,65 +0,54% 1,58% 8.902.200
26/11/2021 69,70 70,74 69,70 70,27 +0,29% 1,49% 5.659.500
24/11/2021 70,74 71,03 69,51 70,07 -0,79% 2,15% 6.737.500
23/11/2021 69,87 70,87 69,71 70,63 +0,94% 1,66% 7.100.400